MetaCap

BioMarin Pharmaceutical Statistics

NASDAQ: BMRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

60.41-1.01 (-1.64%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BioMarin Pharmaceutical by the numbers

BioMarin Pharmaceutical has a market capitalization of $11.70 billion based on 193.69M shares outstanding. With trailing EPS of $-0.10, BioMarin Pharmaceutical is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.6% above its 50-day average and 3.2% above its 200-day average.

Average daily trading volume is 2.35M shares, or about $141.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BMRN valuation vs. peer median

BMRN compared with the median of 8 peer companies
MetricBMRNPeer medianDifference
Market cap$11.70B$10.99B+6%
Forward P/E9.622.5-57%
Avg. volume2.35M1.56M+50%

Peer median across 8 companies: RDY, ELAN, TGTX, JAZZ, BBIO, SYRE, MDGL, PRAX.

Valuation

Market cap
$11.70B
Price / sales (latest FY)
3.63
EPS (TTM)
$-0.10

Price and trading

Previous close
61.42
Open
61.98
Day range
59.84 – 62.00
52-week range
49.26 – 70.98
52-week change
+10.46%
Beta
—
Volume
6.06M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
11.70B
Forward Pe
9.60
Eps
-0.10
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
70.98
Week52 Low
49.26
Avg Volume
2.35M
Shares Outstanding
193.69M
Ma50
58.32
Ma200
58.53
Earnings Date
Nov 2, 2026
Pct From52w High
-14.89%
Pct From52w Low
22.63%

Related